메뉴 건너뛰기




Volumn 401, Issue , 2017, Pages 11-19

Down-regulation of ARID1A is sufficient to initiate neoplastic transformation along with epigenetic reprogramming in non-tumorigenic endometriotic cells

Author keywords

ARID1A; Endometriosis; Epigenetics; Ovarian clear cell carcinoma; Phenotypic transformation

Indexed keywords

DNA BINDING PROTEIN; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PAXILLIN; SHORT HAIRPIN RNA; STRESS ACTIVATED PROTEIN KINASE; ARID1A PROTEIN, HUMAN; HISTONE; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR;

EID: 85019233594     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2017.04.040     Document Type: Article
Times cited : (42)

References (53)
  • 1
    • 84992343107 scopus 로고    scopus 로고
    • United States Cancer Statistics: 1999–2013 Incidence and Mortality Web-based Report
    • U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute Atlanta
    • U.S. Cancer Statistics Working Group, United States Cancer Statistics: 1999–2013 Incidence and Mortality Web-based Report. 2016, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta www.cdc.gov/uscs.
    • (2016)
    • U.S. Cancer Statistics Working Group1
  • 3
    • 41349083323 scopus 로고    scopus 로고
    • Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma
    • Itamochi, H., Kigawa, J., Terakawa, N., Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma. Cancer Sci. 99 (2008), 653–658.
    • (2008) Cancer Sci. , vol.99 , pp. 653-658
    • Itamochi, H.1    Kigawa, J.2    Terakawa, N.3
  • 4
    • 84940462511 scopus 로고    scopus 로고
    • New insights in the pathophysiology of ovarian cancer and implications for screening and prevention
    • Nezhat, F.R., Apostol, R., Nezhat, C., Pejovic, T., New insights in the pathophysiology of ovarian cancer and implications for screening and prevention. Am. J. Obstet. Gynecol. 213 (2015), 262–267.
    • (2015) Am. J. Obstet. Gynecol. , vol.213 , pp. 262-267
    • Nezhat, F.R.1    Apostol, R.2    Nezhat, C.3    Pejovic, T.4
  • 5
    • 79955473637 scopus 로고    scopus 로고
    • Clear cell carcinoma of the ovary: a report from the first ovarian clear cell symposium, June 24th, 2010
    • Anglesio, M.S., Carey, M.S., Köbel, M., MacKay, H., Huntsman, D.G., Clear cell carcinoma of the ovary: a report from the first ovarian clear cell symposium, June 24th, 2010. Gynecol. Oncol. 121 (2011), 407–415.
    • (2011) Gynecol. Oncol. , vol.121 , pp. 407-415
    • Anglesio, M.S.1    Carey, M.S.2    Köbel, M.3    MacKay, H.4    Huntsman, D.G.5
  • 6
    • 84949684655 scopus 로고    scopus 로고
    • Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectives
    • Matsuzaki, S., Yoshino, K., Ueda, Y., Matsuzaki, S., Kakuda, M., Okazawa, A., et al. Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectives. Cancer Cell Int., 15, 2015.
    • (2015) Cancer Cell Int. , vol.15
    • Matsuzaki, S.1    Yoshino, K.2    Ueda, Y.3    Matsuzaki, S.4    Kakuda, M.5    Okazawa, A.6
  • 7
    • 84867269276 scopus 로고    scopus 로고
    • Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma
    • Ayhan, A., Mao, T.-L., Seckin, T., Wu, C.-H., Guan, B., Ogawa, H., et al. Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma. Int. J. Gynecol. Cancer 22 (2012), 1310–1315.
    • (2012) Int. J. Gynecol. Cancer , vol.22 , pp. 1310-1315
    • Ayhan, A.1    Mao, T.-L.2    Seckin, T.3    Wu, C.-H.4    Guan, B.5    Ogawa, H.6
  • 8
    • 79959328816 scopus 로고    scopus 로고
    • Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer–shifting the paradigm
    • Kurman, R.J., Shih, I.M., Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer–shifting the paradigm. Hum. Pathol. 42 (2011), 918–931.
    • (2011) Hum. Pathol. , vol.42 , pp. 918-931
    • Kurman, R.J.1    Shih, I.M.2
  • 9
    • 77957731999 scopus 로고    scopus 로고
    • Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma
    • Jones, S., Wang, T.L., Shih, I.M., Mao, T.L., Nakayama, K., Roden, R., et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 330 (2010), 228–231.
    • (2010) Science , vol.330 , pp. 228-231
    • Jones, S.1    Wang, T.L.2    Shih, I.M.3    Mao, T.L.4    Nakayama, K.5    Roden, R.6
  • 11
    • 79953797962 scopus 로고    scopus 로고
    • Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma
    • Guan, B., Mao, T.-L., Panuganti, P.K., Kuhn, E., Kurman, R.J., Maeda, D., et al. Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma. Am. J. Surg. Pathol. 35 (2011), 625–632.
    • (2011) Am. J. Surg. Pathol. , vol.35 , pp. 625-632
    • Guan, B.1    Mao, T.-L.2    Panuganti, P.K.3    Kuhn, E.4    Kurman, R.J.5    Maeda, D.6
  • 12
    • 79958238185 scopus 로고    scopus 로고
    • Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas
    • Wiegand, K.C., Lee, A.F., Al-Agha, O.M., Chow, C., Kalloger, S.E., Scott, D.W., et al. Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas. J. Pathol. 224 (2011), 328–333.
    • (2011) J. Pathol. , vol.224 , pp. 328-333
    • Wiegand, K.C.1    Lee, A.F.2    Al-Agha, O.M.3    Chow, C.4    Kalloger, S.E.5    Scott, D.W.6
  • 13
    • 84859162183 scopus 로고    scopus 로고
    • Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies
    • Pearce, C.L., Templeman, C., Rossing, M.A., Lee, A., Near, A.M., Webb, P.M., et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies. Lancet Oncol. 13 (2012), 385–394.
    • (2012) Lancet Oncol. , vol.13 , pp. 385-394
    • Pearce, C.L.1    Templeman, C.2    Rossing, M.A.3    Lee, A.4    Near, A.M.5    Webb, P.M.6
  • 14
    • 84859427109 scopus 로고    scopus 로고
    • Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations
    • Yamamoto, S., Tsuda, H., Takano, M., Tamai, S., Matsubara, O., Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations. Mod. Pathol. 25 (2011), 615–624.
    • (2011) Mod. Pathol. , vol.25 , pp. 615-624
    • Yamamoto, S.1    Tsuda, H.2    Takano, M.3    Tamai, S.4    Matsubara, O.5
  • 15
    • 84866024623 scopus 로고    scopus 로고
    • Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma
    • Xiao, W., Awadallah, A., Xin, W., Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma. Int. J. Clin. Exp. Pathol. 5 (2012), 642–650.
    • (2012) Int. J. Clin. Exp. Pathol. , vol.5 , pp. 642-650
    • Xiao, W.1    Awadallah, A.2    Xin, W.3
  • 16
    • 80155131218 scopus 로고    scopus 로고
    • ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers
    • Guan, B., Wang, T.L., Shih, I.M., ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. Cancer Res. 71 (2011), 6718–6727.
    • (2011) Cancer Res. , vol.71 , pp. 6718-6727
    • Guan, B.1    Wang, T.L.2    Shih, I.M.3
  • 19
    • 84992327282 scopus 로고    scopus 로고
    • DNMT3B isoforms without catalytic activity stimulate gene body methylation as accessory proteins in somatic cells
    • Duymich, C.E., Charlet, J., Yang, X., Jones, P.A., Liang, G., DNMT3B isoforms without catalytic activity stimulate gene body methylation as accessory proteins in somatic cells. Nat. Commun., 7, 2016, 11453.
    • (2016) Nat. Commun. , vol.7 , pp. 11453
    • Duymich, C.E.1    Charlet, J.2    Yang, X.3    Jones, P.A.4    Liang, G.5
  • 20
    • 84946221310 scopus 로고    scopus 로고
    • CAUSEL: an epigenome- and genome-editing pipeline for establishing function of noncoding GWAS variants
    • Spisák, S., Lawrenson, K., Fu, Y., Csabai, I., Cottman, R.T., Seo, J.H., et al., G.-O.E. Consortium. CAUSEL: an epigenome- and genome-editing pipeline for establishing function of noncoding GWAS variants. Nat. Med. 21 (2015), 1357–1363.
    • (2015) Nat. Med. , vol.21 , pp. 1357-1363
    • Spisák, S.1    Lawrenson, K.2    Fu, Y.3    Csabai, I.4    Cottman, R.T.5    Seo, J.H.6
  • 21
    • 84870552401 scopus 로고    scopus 로고
    • Genome-wide mapping of nucleosome positioning and DNA methylation within individual DNA molecules
    • Kelly, T.K., Liu, Y., Lay, F.D., Liang, G., Berman, B.P., Jones, P.A., Genome-wide mapping of nucleosome positioning and DNA methylation within individual DNA molecules. Genome Res. 22 (2012), 2497–2506.
    • (2012) Genome Res. , vol.22 , pp. 2497-2506
    • Kelly, T.K.1    Liu, Y.2    Lay, F.D.3    Liang, G.4    Berman, B.P.5    Jones, P.A.6
  • 22
    • 84927704067 scopus 로고    scopus 로고
    • The role of DNA methylation in directing the functional organization of the cancer epigenome
    • Lay, F.D., Liu, Y., Kelly, T.K., Witt, H., Farnham, P.J., Jones, P.A., et al. The role of DNA methylation in directing the functional organization of the cancer epigenome. Genome Res. 25 (2015), 467–477.
    • (2015) Genome Res. , vol.25 , pp. 467-477
    • Lay, F.D.1    Liu, Y.2    Kelly, T.K.3    Witt, H.4    Farnham, P.J.5    Jones, P.A.6
  • 23
    • 84907997839 scopus 로고    scopus 로고
    • Gene body methylation can alter gene expression and is a therapeutic target in cancer
    • Yang, X., Han, H., De Carvalho, Daniel D., Lay, Fides D., Jones, Peter A., Liang, G., Gene body methylation can alter gene expression and is a therapeutic target in cancer. Cancer Cell 26 (2014), 577–590.
    • (2014) Cancer Cell , vol.26 , pp. 577-590
    • Yang, X.1    Han, H.2    De Carvalho, D.D.3    Lay, F.D.4    Jones, P.A.5    Liang, G.6
  • 25
    • 84876836223 scopus 로고    scopus 로고
    • Modification of enhancer chromatin: what, how, and why?
    • Calo, E., Wysocka, J., Modification of enhancer chromatin: what, how, and why?. Mol. Cell 49 (2013), 825–837.
    • (2013) Mol. Cell , vol.49 , pp. 825-837
    • Calo, E.1    Wysocka, J.2
  • 26
    • 84966680811 scopus 로고    scopus 로고
    • Bivalent regions of cytosine methylation and H3K27 acetylation suggest an active role for DNA methylation at enhancers
    • Charlet, J., Duymich, Christopher E., Lay, Fides D., Mundbjerg, K., Dalsgaard Sørensen, K., Liang, G., et al. Bivalent regions of cytosine methylation and H3K27 acetylation suggest an active role for DNA methylation at enhancers. Mol. Cell 62 (2016), 422–431.
    • (2016) Mol. Cell , vol.62 , pp. 422-431
    • Charlet, J.1    Duymich, C.E.2    Lay, F.D.3    Mundbjerg, K.4    Dalsgaard Sørensen, K.5    Liang, G.6
  • 27
    • 34547624303 scopus 로고    scopus 로고
    • Genome-wide maps of chromatin state in pluripotent and lineage-committed cells
    • Mikkelsen, T.S., Ku, M., Jaffe, D.B., Issac, B., Lieberman, E., Giannoukos, G., et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448 (2007), 553–560.
    • (2007) Nature , vol.448 , pp. 553-560
    • Mikkelsen, T.S.1    Ku, M.2    Jaffe, D.B.3    Issac, B.4    Lieberman, E.5    Giannoukos, G.6
  • 28
    • 84862908850 scopus 로고    scopus 로고
    • Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation
    • Li, G., Ruan, X., Auerbach, Raymond K., Sandhu, Kuljeet S., Zheng, M., Wang, P., et al. Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation. Cell 148 (2012), 84–98.
    • (2012) Cell , vol.148 , pp. 84-98
    • Li, G.1    Ruan, X.2    Auerbach, R.K.3    Sandhu, K.S.4    Zheng, M.5    Wang, P.6
  • 29
    • 84938923353 scopus 로고    scopus 로고
    • Inferring regulatory element landscapes and transcription factor networks from cancer methylomes
    • Yao, L., Shen, H., Laird, P.W., Farnham, P.J., Berman, B.P., Inferring regulatory element landscapes and transcription factor networks from cancer methylomes. Genome Biol., 16, 2015.
    • (2015) Genome Biol. , vol.16
    • Yao, L.1    Shen, H.2    Laird, P.W.3    Farnham, P.J.4    Berman, B.P.5
  • 30
    • 84943987463 scopus 로고
    • Multiple comparisons among means
    • Dunn, O., Multiple comparisons among means. J. Am. Stat. Assoc. 56 (1961), 52–64.
    • (1961) J. Am. Stat. Assoc. , vol.56 , pp. 52-64
    • Dunn, O.1
  • 31
    • 34548459014 scopus 로고    scopus 로고
    • Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy
    • Cornelio, D.B., Roesler, R., Schwartsmann, G., Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy. Ann. Oncol. 18 (2007), 1457–1466.
    • (2007) Ann. Oncol. , vol.18 , pp. 1457-1466
    • Cornelio, D.B.1    Roesler, R.2    Schwartsmann, G.3
  • 32
    • 84905735682 scopus 로고    scopus 로고
    • Loss of HSulf-1 expression enhances tumorigenicity by inhibiting Bim expression in ovarian cancer
    • He, X., Khurana, A., Roy, D., Kaufmann, S., Shridhar, V., Loss of HSulf-1 expression enhances tumorigenicity by inhibiting Bim expression in ovarian cancer. Int. J. Cancer 135 (2014), 1783–1789.
    • (2014) Int. J. Cancer , vol.135 , pp. 1783-1789
    • He, X.1    Khurana, A.2    Roy, D.3    Kaufmann, S.4    Shridhar, V.5
  • 33
    • 0029055784 scopus 로고
    • Paxillin, a tyrosine phosphorylated focal adhesion-associated protein binds to the carboxyl terminal domain of focal adhesion kinase
    • Hildebrand, J.D., Schaller, M.D., Parsons, J.T., Paxillin, a tyrosine phosphorylated focal adhesion-associated protein binds to the carboxyl terminal domain of focal adhesion kinase. Mol. Biol. Cell 6 (1995), 637–647.
    • (1995) Mol. Biol. Cell , vol.6 , pp. 637-647
    • Hildebrand, J.D.1    Schaller, M.D.2    Parsons, J.T.3
  • 34
    • 17344362877 scopus 로고    scopus 로고
    • Signaling by integrin receptors
    • Kumar, C.C., Signaling by integrin receptors. Oncogene 17 (1998), 1365–1373.
    • (1998) Oncogene , vol.17 , pp. 1365-1373
    • Kumar, C.C.1
  • 35
    • 84899563093 scopus 로고    scopus 로고
    • RASSF1A promotes apoptosis and suppresses the proliferation of ovarian cancer cells
    • Fu, L., Zhang, S., RASSF1A promotes apoptosis and suppresses the proliferation of ovarian cancer cells. Int. J. Mol. Med., 2014.
    • (2014) Int. J. Mol. Med.
    • Fu, L.1    Zhang, S.2
  • 37
    • 0344237221 scopus 로고    scopus 로고
    • Roles of luteinizing hormone/chorionic gonadotropin receptor in anchorage-dependent and -independent growth in human ovarian surface epithelial cell lines
    • Tashiro, H., Katabuchi, H., Begum, M., Li, X., Nitta, M., Ohtake, H., et al. Roles of luteinizing hormone/chorionic gonadotropin receptor in anchorage-dependent and -independent growth in human ovarian surface epithelial cell lines. Cancer Sci. 94 (2003), 953–959.
    • (2003) Cancer Sci. , vol.94 , pp. 953-959
    • Tashiro, H.1    Katabuchi, H.2    Begum, M.3    Li, X.4    Nitta, M.5    Ohtake, H.6
  • 38
    • 84971238313 scopus 로고    scopus 로고
    • TNF-α expression, risk factors, and inflammatory exposures in ovarian cancer: evidence for an inflammatory pathway of ovarian carcinogenesis?
    • Gupta, M., Babic, A., Beck, A.H., Terry, K., TNF-α expression, risk factors, and inflammatory exposures in ovarian cancer: evidence for an inflammatory pathway of ovarian carcinogenesis?. Hum. Pathol. 54 (2016), 82–91.
    • (2016) Hum. Pathol. , vol.54 , pp. 82-91
    • Gupta, M.1    Babic, A.2    Beck, A.H.3    Terry, K.4
  • 39
    • 83255188897 scopus 로고    scopus 로고
    • Polycomb-repressed genes have permissive enhancers that initiate reprogramming
    • Taberlay, Phillippa C., Kelly, Theresa K., Liu, C.-C., You, Jueng S., De Carvalho, Daniel D., Miranda, Tina B., et al. Polycomb-repressed genes have permissive enhancers that initiate reprogramming. Cell 147 (2011), 1283–1294.
    • (2011) Cell , vol.147 , pp. 1283-1294
    • Taberlay, P.C.1    Kelly, T.K.2    Liu, C.-C.3    You, J.S.4    De Carvalho, D.D.5    Miranda, T.B.6
  • 40
    • 77952414230 scopus 로고    scopus 로고
    • Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET Oncogene in bladders with cancer
    • Wolff, E.M., Byun, H.-M., Han, H.F., Sharma, S., Nichols, P.W., Siegmund, K.D., et al. Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET Oncogene in bladders with cancer. PLoS Genet., 6, 2010, e1000917.
    • (2010) PLoS Genet. , vol.6 , pp. e1000917
    • Wolff, E.M.1    Byun, H.-M.2    Han, H.F.3    Sharma, S.4    Nichols, P.W.5    Siegmund, K.D.6
  • 41
    • 84925502851 scopus 로고    scopus 로고
    • Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers
    • Bitler, B.G., Aird, K.M., Garipov, A., Li, H., Amatangelo, M., Kossenkov, A.V., et al. Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers. Nat. Med., 2015.
    • (2015) Nat. Med.
    • Bitler, B.G.1    Aird, K.M.2    Garipov, A.3    Li, H.4    Amatangelo, M.5    Kossenkov, A.V.6
  • 42
    • 84949551829 scopus 로고    scopus 로고
    • SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2
    • Kim, K.H., Kim, W., Howard, T.P., Vazquez, F., Tsherniak, A., Wu, J.N., et al. SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2. Nat. Med. 21 (2015), 1491–1496.
    • (2015) Nat. Med. , vol.21 , pp. 1491-1496
    • Kim, K.H.1    Kim, W.2    Howard, T.P.3    Vazquez, F.4    Tsherniak, A.5    Wu, J.N.6
  • 43
    • 84962921733 scopus 로고    scopus 로고
    • Suppression of the SWI/SNF component ARID1A promotes mammalian regeneration
    • Sun, X., Chuang, J.-C., Kanchwala, M., Wu, L., Celen, C., Li, L., et al. Suppression of the SWI/SNF component ARID1A promotes mammalian regeneration. Cell Stem Cell 18 (2016), 456–466.
    • (2016) Cell Stem Cell , vol.18 , pp. 456-466
    • Sun, X.1    Chuang, J.-C.2    Kanchwala, M.3    Wu, L.4    Celen, C.5    Li, L.6
  • 45
    • 0016318441 scopus 로고
    • Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium
    • Freedman, V., Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell 3 (1974), 355–359.
    • (1974) Cell , vol.3 , pp. 355-359
    • Freedman, V.1
  • 46
    • 68349125561 scopus 로고    scopus 로고
    • Anchorage-independent cell growth signature identifies tumors with metastatic potential
    • Mori, S., Chang, J.T., Andrechek, E.R., Matsumura, N., Baba, T., Yao, G., et al. Anchorage-independent cell growth signature identifies tumors with metastatic potential. Oncogene 28 (2009), 2796–2805.
    • (2009) Oncogene , vol.28 , pp. 2796-2805
    • Mori, S.1    Chang, J.T.2    Andrechek, E.R.3    Matsumura, N.4    Baba, T.5    Yao, G.6
  • 47
    • 1042267263 scopus 로고    scopus 로고
    • Cell adhesion and signalling by cadherins and Ig-CAMs in cancer
    • Cavallaro, U., Christofori, G., Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat. Rev. Cancer 4 (2004), 118–132.
    • (2004) Nat. Rev. Cancer , vol.4 , pp. 118-132
    • Cavallaro, U.1    Christofori, G.2
  • 48
    • 66049088456 scopus 로고    scopus 로고
    • Combined integrin phosphoproteomic analyses and small interfering RNA-based functional screening identify key regulators for cancer cell adhesion and migration
    • Chen, Y., Lu, B., Yang, Q., Fearns, C., Yates, J.R., Lee, J.D., Combined integrin phosphoproteomic analyses and small interfering RNA-based functional screening identify key regulators for cancer cell adhesion and migration. Cancer Res. 69 (2009), 3713–3720.
    • (2009) Cancer Res. , vol.69 , pp. 3713-3720
    • Chen, Y.1    Lu, B.2    Yang, Q.3    Fearns, C.4    Yates, J.R.5    Lee, J.D.6
  • 49
    • 84953240912 scopus 로고    scopus 로고
    • Genome-wide transcriptional regulation mediated by biochemically distinct SWI/SNF complexes
    • Raab, J.R., Resnick, S., Magnuson, T., Genome-wide transcriptional regulation mediated by biochemically distinct SWI/SNF complexes. PLoS Genet., 11, 2015, e1005748.
    • (2015) PLoS Genet. , vol.11 , pp. e1005748
    • Raab, J.R.1    Resnick, S.2    Magnuson, T.3
  • 50
    • 84989853721 scopus 로고    scopus 로고
    • Loss of HDAC-mediated repression and gain of NF-κB activation underlie cytokine induction in ARID1A- and PIK3CA-mutation-driven ovarian cancer
    • Kim, M., Lu, F., Zhang, Y., Loss of HDAC-mediated repression and gain of NF-κB activation underlie cytokine induction in ARID1A- and PIK3CA-mutation-driven ovarian cancer. Cell Rep. 17 (2016), 275–288.
    • (2016) Cell Rep. , vol.17 , pp. 275-288
    • Kim, M.1    Lu, F.2    Zhang, Y.3
  • 51
    • 0034737290 scopus 로고    scopus 로고
    • Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF
    • Zhang, H.S., Gavin, M., Dahiya, A., Postigo, A.A., Ma, D., Luo, R.X., et al. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 101 (2000), 79–89.
    • (2000) Cell , vol.101 , pp. 79-89
    • Zhang, H.S.1    Gavin, M.2    Dahiya, A.3    Postigo, A.A.4    Ma, D.5    Luo, R.X.6
  • 53
    • 32944462571 scopus 로고    scopus 로고
    • Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas
    • Hendrix, N.D., Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas. Cancer Res. 66 (2006), 1354–1362.
    • (2006) Cancer Res. , vol.66 , pp. 1354-1362
    • Hendrix, N.D.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.